Results of base case analysis (five scenarios)
| Base case analysis and comparator | Mean cost per patient | Incremental cost# |
| Sputum smear-positive TB suspects | ||
| Xpert MTB/RIF as an add-on | 157.2 | 0 |
| Conventional approach | 205.47 | 48.27 |
| Sputum smear-positive MDR-TB suspects | ||
| Xpert MTB/RIF as an add-on | 240.93 | 0 |
| Conventional approach | 430.49 | 189.56 |
| Sputum smear-negative TB suspects | ||
| Xpert MTB/RIF as an add-on | 512.17 | 0 |
| Conventional approach | 1015.17 | 503.0 |
| Sputum smear-negative MDR-TB suspects | ||
| Xpert MTB/RIF as an add-on | 518.03 | 0 |
| Conventional approach | 1033.28 | 515.25 |
| Xpert MTB/RIF replacing smears | ||
| Xpert MTB/RIF | 440.97 | 0 |
| Conventional approach | 890.95 | 449.98 |
Costs are presented as €. TB: tuberculosis; MDR: multidrug-resistant. #: increase in total costs resulting from using the conventional approach alone versus including Xpert MTB/RIF as an add-on or as a replacement.